anti-osteoporosis agents (Biosolomon)

N/A

Report date: 2025/05/13 16:53:12

Base Information

Drug Nameanti-osteoporosis agents (Biosolomon)
Drug Alias Name(-)-cryptotanshinone15,16-dihydrotanshinone-Icryptotanshinonecryptotanshinone (Biosolomon)tanshinone I +[10] 
ClassificationNatural product/Extract
Mechanisms of ActionCorticosteroid 11-beta-dehydrogenase isozyme 1 inhibitorsAcetylcholinesterase inhibitorsAldose reductase inhibitors +[6] 
TargetsCorticosteroid 11-beta-dehydrogenase isozyme 1AcetylcholinesteraseAldose reductase +[4] 
Therapy Area/IndicationsOsteoporosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBiosolomon Inc
China Registration ClassN/A

Develop Information

Active CompaniesBiosolomon Inc
Inactive CompaniesN/A
Active IndicationsOsteoporosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A